A Novel Cisplatin-Based Prodrug Inhibits Lysine Deacetylases, Suppresses Nucleotide Excision Repair, and Overcomes Resistance
Ya’ara Negev-Korem, Esther Stern, Hadar Golan-Berman…·Sheera Adar
This study develops a novel cisplatin-based prodrug that inhibits lysine deacetylases and suppresses nucleotide excision repair, enhancing cisplatin's cytotoxicity and overcoming resistance.